Grace Therapeutics, Inc.
GRCE
$3.00
-$0.035-1.15%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/3/2025
-
Ticker Report
5/2/2025
-
GuruFocus
5/2/2025
-
The Fly
4/10/2025
-
TipRanks Financial Blog
4/9/2025
-
GuruFocus
4/9/2025
-
TipRanks Financial Blog
4/9/2025
-
Globe Newswire
3/10/2025
-
The Fly
2/25/2025
-
GuruFocus
2/25/2025
-
Globe Newswire
2/13/2025
-
The Fly
2/13/2025
-
SeekingAlpha.com: All News
2/13/2025
-
Globe Newswire
2/11/2025
-
The Fly
2/10/2025
-
Seeking Alpha - Healthcare
2/10/2025
-
GuruFocus
2/10/2025
-
The Fly
2/10/2025
-
The Fly
2/10/2025
-
Globe Newswire
2/10/2025
-
Globe Newswire
1/28/2025
-
TipRanks Financial Blog
1/7/2025
-
GuruFocus
1/7/2025
-
Globe Newswire
12/20/2024
-
Simply Wall St
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Jun 16 and 20 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
818 839 4378
Address
103 Carnegie Center
Princeton, NJ 08540
Princeton, NJ 08540
Country
Year Founded
Business Description
Sector
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company’s lead product candidate is the GTX-104...
more